Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Akad. Kuprevicha st. 5/2, Minsk 220141, Belarus.
Department of Experimental Tumor Biology, Blokhin N.N. National Medical Research Center of Oncology, Kashirskoye sh. 24, Moscow 115522, Russian Federation.
Org Biomol Chem. 2021 Dec 8;19(47):10432-10443. doi: 10.1039/d1ob01614h.
An effective method for the synthesis of 8-aryl-4,5-dihydrothiazolo[4',5':3,4]benzo[1,2-]isoxazol-2-amines was developed. This method includes the α-keto bromination of 3-aryl-6,7-dihydrobenzo[]isoxazol-4(5)-ones followed by the condensation of the obtained bromo derivatives with thiourea in acetonitrile. Using virtual screening, a series of acylated derivatives of the obtained compounds were selected as potential HSP90 inhibitors. These compounds were prepared and evaluated as antiproliferative agents against three cancer cell lines (A431, 22Rv1, and MCF-7). Compounds 8b, 8c and 8q exhibiting high antiproliferative potency against MCF-7 breast cancer cells with IC values ranging from 2.3 to 9.5 μM were chosen for in-depth evaluation. The selected compounds had remarkable effects on HSP90 client proteins, including steroid hormone receptors and the anti-apoptotic factor BCL2. The obtained compounds are of interest for anticancer drug development.
开发了一种合成 8-芳基-4,5-二氢噻唑并[4',5':3,4]苯并[1,2-]异噁唑-2-胺的有效方法。该方法包括 3-芳基-6,7-二氢苯并[]异噁唑-4(5)-酮的α-酮溴化,然后在乙腈中用硫脲缩合得到的溴代衍生物。通过虚拟筛选,选择了一系列获得的化合物的酰化衍生物作为潜在的 HSP90 抑制剂。这些化合物被制备并评估为对三种癌细胞系(A431、22Rv1 和 MCF-7)的抗增殖剂。选择了具有高抗 MCF-7 乳腺癌细胞增殖活性(IC 值范围为 2.3 至 9.5 μM)的化合物 8b、8c 和 8q 进行深入评估。所选化合物对 HSP90 客户蛋白(包括甾体激素受体和抗凋亡因子 BCL2)有显著影响。获得的化合物对开发抗癌药物具有重要意义。